Lotte Non - Life Insurance Co., Ltd. (KRX:000400)
South Korea · Delayed Price · Currency is KRW 2,135.00
-20.00 (-0.93%)
Apr 21, 2026, 3:30 PM KST
KRX:000400 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 2,005,634 | 1,850,449 | 1,528,457 | 1,344,959 | 2,012,148 |
Total Interest & Dividend Income | 483,416 | 491,180 | 512,412 | 534,692 | 122,011 |
Gain (Loss) on Sale of Investments | 162,223 | 205,383 | 224,766 | 103,806 | 43,508 |
Other Revenue | 129,423 | 53,278 | 97,930 | 87,222 | 142,647 |
| 2,780,696 | 2,600,290 | 2,363,565 | 2,070,679 | 2,320,314 | |
Revenue Growth (YoY) | 6.94% | 10.02% | 14.14% | -10.76% | -22.83% |
Policy Benefits | 2,096,268 | 1,808,983 | 1,190,615 | 1,344,194 | 1,614,871 |
Policy Acquisition & Underwriting Costs | 10,846 | 8,457 | 8,914 | 3,595 | 253,787 |
Amortization of Goodwill & Intangibles | 16,750 | 16,981 | 21,673 | 12,060 | 11,583 |
Depreciation & Amortization | 8 | 8 | 8 | 8 | 11,812 |
Selling, General & Administrative | 30,171 | 28,311 | 22,919 | 11,003 | 93,932 |
Other Operating Expenses | 203,479 | 372,043 | 189,955 | 194,780 | 133,273 |
Reinsurance Income or Expense | - | - | - | - | -2,144 |
Total Operating Expenses | 2,376,819 | 2,269,757 | 1,469,977 | 1,580,914 | 2,210,260 |
Operating Income | 403,877 | 330,533 | 893,588 | 489,765 | 110,054 |
Interest Expense | -296,560 | -350,330 | -349,868 | -231,558 | -21,179 |
Earnings From Equity Investments | -527 | -538 | -541.23 | -326.5 | - |
Currency Exchange Gain (Loss) | 50,651 | 266,389 | 70,232 | 109,792 | 75,523 |
Other Non Operating Income (Expenses) | -420 | 2,807 | -1,411 | -6,274 | 27,084 |
EBT Excluding Unusual Items | 157,021 | 248,861 | 612,000 | 361,399 | 191,482 |
Gain (Loss) on Sale of Investments | -93,232 | -215,531 | -217,661 | -493,129 | -34,994 |
Pretax Income | 63,789 | 33,330 | 394,339 | -131,731 | 156,488 |
Income Tax Expense | 12,458 | 9,108 | 92,703 | -32,528 | 36,610 |
Net Income | 51,331 | 24,222 | 301,636 | -99,202 | 119,878 |
Preferred Dividends & Other Adjustments | - | - | 3,128 | - | - |
Net Income to Common | 51,331 | 24,222 | 298,508 | -99,202 | 119,878 |
Net Income Growth | 111.92% | -91.97% | - | - | - |
Shares Outstanding (Basic) | - | 309 | 309 | 309 | 309 |
Shares Outstanding (Diluted) | - | 309 | 309 | 309 | 309 |
EPS (Basic) | - | 78.36 | 965.70 | -320.93 | 387.82 |
EPS (Diluted) | - | 78.36 | 965.70 | -320.93 | 387.82 |
EPS Growth | - | -91.89% | - | - | - |
Free Cash Flow | -735,313 | -221,142 | 2,105,407 | -417,851 | 103,305 |
Free Cash Flow Per Share | - | -715.41 | 6811.19 | -1351.79 | 334.20 |
Operating Margin | 14.52% | 12.71% | 37.81% | 23.65% | 4.74% |
Profit Margin | 1.85% | 0.93% | 12.63% | -4.79% | 5.17% |
Free Cash Flow Margin | -26.44% | -8.51% | 89.08% | -20.18% | 4.45% |
EBITDA | 440,808 | 367,374 | 933,876 | 516,507 | 134,037 |
EBITDA Margin | 15.85% | 14.13% | 39.51% | 24.94% | 5.78% |
D&A For EBITDA | 36,931 | 36,841 | 40,288 | 26,742 | 23,983 |
EBIT | 403,877 | 330,533 | 893,588 | 489,765 | 110,054 |
EBIT Margin | 14.52% | 12.71% | 37.81% | 23.65% | 4.74% |
Effective Tax Rate | 19.53% | 27.33% | 23.51% | - | 23.39% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.